Subscribe to Newsletter

Discovery & Development

Discovery & Development Formulation

Superbugs Versus Supercomputers

| Jamie Irvine | 2 min read

Developments in antivirulence drug treatments could solve the threat of antimicrobial resistance

Discovery & Development Formulation

The Fountain of Youth

| Jamie Irvine | 6 min read

Anti-aging company – Five Alarm Bio – reveal their discoveries on safe and effective treatments for age-associated diseases and disabilities

Discovery & Development Formulation

Llamas – and Yeast Display – to the Rescue

| Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Drug Delivery

Power List Perspectives: Challenges Facing Cell and Gene Therapy

| Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Drug Discovery

Meet the New Wave of Therapeutic Antibodies

| Sponsored by Bio-Rad Laboratories | 6 min read

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Discovery & Development Drug Discovery

Retinal Regeneration

| 3 min read

Endogena Therapeutics CEO Matthias Steger discusses fast track FDA approval for EA-2353, a new drug for the treatment of retinitis pigmentosa

Discovery & Development Formulation

T Cell Bright Spark

| 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Discovery & Development Drug Discovery

The Antibody Saga – Key Milestones and Big Predictions

| Sponsored by Bio-Rad Laboratories | 8 min read

Will next gen antibodies knock our socks off? Experts consider the future of antibody-based drug development

Discovery & Development Drug Discovery

The Antibody Discovery Challenge

| Sponsored by Bio-Rad Laboratories | 6 min read

What lies ahead for antibody discovery? We ask experts from RQ Bio.

Discovery & Development Drug Discovery

Time for (CAR) T

| Stephanie Vine | 6 min read

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register